
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals: Innovating treatments for rare and age-related diseases since 2012.
- 13
- Series B
Founded in 2012, Aeovian Pharmaceuticals is a biopharmaceutical company based in the San Francisco Bay Area. The company's core mission is to discover, develop, and commercialize innovative therapeutics for treating rare and age-related diseases. Aeovian focuses on developing compounds that modulate molecular pathways to address the underlying causes of disease initiation and progression, such as oxidative, cellular, and environmental stress. Their lead development candidate, AV078, is currently in Phase clinical trials for treating seizures associated with Tuberous Sclerosis Complex (TSC).
Notable figures affiliated with Aeovian Pharmaceuticals include William Greene, MD, CIO at Hevolution, and Justin Gover, former CEO at GW Pharmaceuticals, both of whom have joined the board. The company has achieved significant milestones, including dosing the first cohort of participants in their Phase clinical trial and securing additional financing. Aeovian's innovative approach and strategic leadership have positioned it as a promising player in the biopharmaceutical industry, with a focus on impactful treatments for underserved patient populations.
Similar Companies

Azevan Pharmaceuticals
azevan.com

Avalyn Pharma
avalynpharma.com

Aria Pharmaceuticals

Abvc Biopharma

Avior Bio

Aquavit Pharmaceuticals
aquavitpharma.com

Apexian Pharmaceuticals
apexianpharma.com

Aether Therapeutics

Alzheon
alzheon.com

Biohaven
biohaven.com

Aegle Therapeutics

Navitor Pharmaceuticals

Aquestive Therapeutics
aquestive.com

Woolsey Pharmaceuticals
woolseypharma.com

Riparian Pharmaceuticals
Quick Facts
Who are Aeovian Pharmaceuticals' competitors?
Companies similar to Aeovian Pharmaceuticals include Azevan Pharmaceuticals, Avalyn Pharma, Aria Pharmaceuticals and Abvc Biopharma.
When was Aeovian Pharmaceuticals founded?
Aeovian Pharmaceuticals was founded in 2012.
Where is Aeovian Pharmaceuticals' headquarters located?
Aeovian Pharmaceuticals' headquarters is located in San Francisco, CA, US.
How much disclosed funding has Aeovian Pharmaceuticals raised?
As of the latest available date, Aeovian Pharmaceuticals has disclosed funding of $142.8M (USD). Undisclosed round amounts are excluded.
How many employees does Aeovian Pharmaceuticals have?
Aeovian Pharmaceuticals has 13 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified